Improved Survival of Patients with Metastatic Breast Cancer in Routine Care: Results of a Retrospective Study in a Community-Based Oncology Group Practice 1995–2005

Publisher： Karger

E-ISSN： 2296-5262|32|3|107-113

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.3, 2009-02, pp. : 107-113

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outpatient Therapy in Metastatic Breast Cancer. A Retrospective Study of 90 Patients Treated in an Oncology Group Practice

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 380-384

Karger

Access to resources Recommend Favorite

Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study

By Gümüşş Mahmut   Davidson Neville   Bauknecht Thomas   Soldatenkova Victoria   Benhadji Karim A  

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 401-413

Informa Healthcare

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 147-151

Karger

Access to resources Recommend Favorite

Weekly Docetaxel with or without Gemcitabine as Second-Line Chemotherapy in Paclitaxel-Pretreated Patients with Metastatic Breast Cancer: A Randomized Phase II Study Conducted by the Hellenic Co-Operative Oncology Group

By  

Oncology, Vol. 77, Iss. 3-4, 2009-09 ,pp. : 212-216

Karger

Access to resources Recommend Favorite

Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III ‘Stop and Go' Study Results - A Turkish Oncology Group Trial

By  

Oncology, Vol. 85, Iss. 6, 2013-11 ,pp. : 328-335

Karger

Access to resources Recommend Favorite